IBEX LTD (IBEX) Stock Fundamental Analysis
USA - NASDAQ:IBEX - BMG4690M1010 - Common Stock
36.86 USD
-0.56 (-1.5%)
36.86 USD
0 (0%)
IBEX gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 85 industry peers in the IT Services industry. Both the health and profitability get an excellent rating, making IBEX a very profitable company, without any liquidiy or solvency issues. IBEX has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! These ratings would make IBEX suitable for value and growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year IBEX was profitable.
In the past year IBEX had a positive cash flow from operations.
In the past 5 years IBEX has always been profitable.
In the past 5 years IBEX always reported a positive cash flow from operatings.
1.2 Ratios
IBEX's Return On Assets of 13.49% is amongst the best of the industry. IBEX outperforms 94.12% of its industry peers.
Looking at the Return On Equity, with a value of 27.45%, IBEX belongs to the top of the industry, outperforming 90.59% of the companies in the same industry.
IBEX has a Return On Invested Capital of 20.43%. This is amongst the best in the industry. IBEX outperforms 92.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.49% | ||
| ROE | 27.45% | ||
| ROIC | 20.43% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
IBEX has a Profit Margin of 6.60%. This is in the better half of the industry: IBEX outperforms 70.59% of its industry peers.
In the last couple of years the Profit Margin of IBEX has grown nicely.
IBEX has a Operating Margin of 8.71%. This is in the better half of the industry: IBEX outperforms 64.71% of its industry peers.
IBEX's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 30.91%, IBEX is in line with its industry, outperforming 42.35% of the companies in the same industry.
In the last couple of years the Gross Margin of IBEX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.71% | ||
| PM (TTM) | 6.6% | ||
| GM | 30.91% |
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IBEX is creating value.
There is no outstanding debt for IBEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 5.20 indicates that IBEX is not in any danger for bankruptcy at the moment.
IBEX's Altman-Z score of 5.20 is fine compared to the rest of the industry. IBEX outperforms 70.59% of its industry peers.
IBEX has a debt to FCF ratio of 0.06. This is a very positive value and a sign of high solvency as it would only need 0.06 years to pay back of all of its debts.
IBEX has a better Debt to FCF ratio (0.06) than 94.12% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that IBEX is not too dependend on debt financing.
IBEX has a better Debt to Equity ratio (0.01) than 82.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.06 | ||
| Altman-Z | 5.2 |
ROIC/WACC2.24
WACC9.12%
2.3 Liquidity
IBEX has a Current Ratio of 1.82. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.82, IBEX perfoms like the industry average, outperforming 55.29% of the companies in the same industry.
IBEX has a Quick Ratio of 1.82. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.82, IBEX perfoms like the industry average, outperforming 57.65% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 32.08% over the past year.
The Earnings Per Share has been growing by 41.04% on average over the past years. This is a very strong growth
The Revenue has grown by 9.78% in the past year. This is quite good.
IBEX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.62% yearly.
EPS 1Y (TTM)32.08%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%50%
Revenue 1Y (TTM)9.78%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%18.15%
3.2 Future
The Earnings Per Share is expected to grow by 12.11% on average over the next years. This is quite good.
Based on estimates for the next years, IBEX will show a quite strong growth in Revenue. The Revenue will grow by 8.28% on average per year.
EPS Next Y16.57%
EPS Next 2Y12.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.8%
Revenue Next 2Y8.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 13.16, IBEX is valued correctly.
Based on the Price/Earnings ratio, IBEX is valued cheaply inside the industry as 83.53% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 25.67. IBEX is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 11.29, which indicates a very decent valuation of IBEX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IBEX indicates a rather cheap valuation: IBEX is cheaper than 81.18% of the companies listed in the same industry.
IBEX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 31.86.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.16 | ||
| Fwd PE | 11.29 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IBEX is valued cheaply inside the industry as 85.88% of the companies are valued more expensively.
68.24% of the companies in the same industry are more expensive than IBEX, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.99 | ||
| EV/EBITDA | 7.36 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IBEX has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as IBEX's earnings are expected to grow with 12.11% in the coming years.
PEG (NY)0.79
PEG (5Y)0.32
EPS Next 2Y12.11%
EPS Next 3YN/A
5. Dividend
5.1 Amount
IBEX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
36.86
-0.56 (-1.5%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners94.9%
Inst Owner Change-0.54%
Ins Owners8.95%
Ins Owner Change-3.95%
Market Cap490.98M
Revenue(TTM)558.27M
Net Income(TTM)36.86M
Analysts45.71
Price Target39.27 (6.54%)
Short Float %1.29%
Short Ratio0.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.37%
Min EPS beat(2)10.89%
Max EPS beat(2)21.85%
EPS beat(4)4
Avg EPS beat(4)13.65%
Min EPS beat(4)7.33%
Max EPS beat(4)21.85%
EPS beat(8)7
Avg EPS beat(8)11.1%
EPS beat(12)10
Avg EPS beat(12)14.9%
EPS beat(16)11
Avg EPS beat(16)6.92%
Revenue beat(2)2
Avg Revenue beat(2)6.82%
Min Revenue beat(2)5.12%
Max Revenue beat(2)8.52%
Revenue beat(4)4
Avg Revenue beat(4)4.42%
Min Revenue beat(4)1.58%
Max Revenue beat(4)8.52%
Revenue beat(8)4
Avg Revenue beat(8)1.31%
Revenue beat(12)4
Avg Revenue beat(12)-0.58%
Revenue beat(16)6
Avg Revenue beat(16)-0.56%
PT rev (1m)0%
PT rev (3m)26.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)18.55%
EPS NY rev (1m)0%
EPS NY rev (3m)4.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.66%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.16 | ||
| Fwd PE | 11.29 | ||
| P/S | 0.88 | ||
| P/FCF | 17.99 | ||
| P/OCF | 10.75 | ||
| P/B | 3.66 | ||
| P/tB | 4.02 | ||
| EV/EBITDA | 7.36 |
EPS(TTM)2.8
EY7.6%
EPS(NY)3.26
Fwd EY8.86%
FCF(TTM)2.05
FCFY5.56%
OCF(TTM)3.43
OCFY9.3%
SpS41.91
BVpS10.08
TBVpS9.16
PEG (NY)0.79
PEG (5Y)0.32
Graham Number25.2
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.49% | ||
| ROE | 27.45% | ||
| ROCE | 25.17% | ||
| ROIC | 20.43% | ||
| ROICexc | 22.19% | ||
| ROICexgc | 23.83% | ||
| OM | 8.71% | ||
| PM (TTM) | 6.6% | ||
| GM | 30.91% | ||
| FCFM | 4.89% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
F-Score8
Asset Turnover2.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.06 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 106.63% | ||
| Cap/Sales | 3.29% | ||
| Interest Coverage | 29.77 | ||
| Cash Conversion | 69.33% | ||
| Profit Quality | 74.04% | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 | ||
| Altman-Z | 5.2 |
F-Score8
WACC9.12%
ROIC/WACC2.24
Cap/Depr(3y)83.97%
Cap/Depr(5y)108.52%
Cap/Sales(3y)2.89%
Cap/Sales(5y)3.72%
Profit Quality(3y)75.63%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.08%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%50%
EPS Next Y16.57%
EPS Next 2Y12.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.78%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%18.15%
Revenue Next Year10.8%
Revenue Next 2Y8.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.91%
EBIT growth 3Y33.16%
EBIT growth 5Y20.06%
EBIT Next Year66.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.92%
FCF growth 3Y24.66%
FCF growth 5Y-10.09%
OCF growth 1Y27.21%
OCF growth 3Y4.51%
OCF growth 5Y-2.46%
IBEX LTD / IBEX FAQ
Can you provide the ChartMill fundamental rating for IBEX LTD?
ChartMill assigns a fundamental rating of 7 / 10 to IBEX.
Can you provide the valuation status for IBEX LTD?
ChartMill assigns a valuation rating of 7 / 10 to IBEX LTD (IBEX). This can be considered as Undervalued.
What is the profitability of IBEX stock?
IBEX LTD (IBEX) has a profitability rating of 7 / 10.
Can you provide the financial health for IBEX stock?
The financial health rating of IBEX LTD (IBEX) is 7 / 10.
Can you provide the expected EPS growth for IBEX stock?
The Earnings per Share (EPS) of IBEX LTD (IBEX) is expected to grow by 16.57% in the next year.